Bivalent cations involvement in opiates addiction

• Autorzy: Nechifor M
• Języki publikacji: EN

Abstrakty

EN

Bivalent cations from brain influence many normal and pathological processes. Pharmacodependences are among the pathological processes were some bivalent cations are involved. The effects of these cations on opiate addiction are different. Generally, the links between intra or extra cellular concentrations of bivalent cations have modulatory effect on intensity of opiate addiction and symptoms of withdrawal syndrome. Calcium enhances intensity of opiate addiction. Our data show that magnesium diminished almost all symptoms from withdrawal in morphine-induced addiction. Manganese and zinc administrated during emerging morphine addiction in rat decreases significantly and specifically some symptoms during withdrawal syndrome. Copper doesn't influence significantly either intensity of addiction or symptoms from withdrawal syndrome if it is administered during expression faze. Alimentary intake or therapy with these cations may change intensity of opiate addiction.

Słowa kluczowe

EN

pathological process; manganese; magnesium; bivalent cation; brain; central nervous system; pathology; human disease; calcium; opiate addiction; zinc; copper; psychiatric disease; normal process

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2007
• Tom: 34
• Numer: 1-2
• Opis fizyczny: p.36-40,ref.

Twórcy

autor

Nechifor M

• University of Medicine and Pharmacy, Gr.T.Popa Iasi, Romania

Bibliografia

• 1. Alves G., Thiebot J., Tracqui A. et al.: Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. JPEN J Parenter. Enteral. Nutr. 1997, 21(1), 41.
• 2. Barrios M, Baeyens JM.: Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine. Psychopharmacology (Berl) 1991, 4, 397.
• 3. Bhargava H.N.: The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and -dependent mice. Psychopharmacology (Berl). 1978, 57(2), 223.
• 4. Biala G., Langwinski R.: Effects of calcium channel antagonists on the reinforcing properties of morphine, ethanol and cocaine as measured by place conditioning. J. Physiol. Pharmacol. 1996, 47(3), 497.
• 5. Blackburn-Munro G„ Brown C.H., Neumann I.D. et al.: Verapamil prevents withdrawal excitation of oxytocin neurones in morphine-dependent rats.Neuropharmacology. 2000;39(9):1596.
• 6. Butterworth R.F., Spahr L., Fontaine S. et al.: Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab. Brain Dis. 1995, 10(4), 259.
• 7. Cerezo M„ Laorden M.L., Milanes M.V.: Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis. Eur. J. Pharmacol. 2002, 452, 57.
• 8. Ciubotariu D., Nechifor M. Chelarescu D. et al.: The influence of zinc ions on morphine induced pharmacodependence in rat, 5th International Symposium on Trace Elements in Human: New Perspectives, Athens, 2005, p. 60.
• 9. Dogrul A., Żagli U., Tulunay F.C. et al.: The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome. Life Sei. 2002, 71(6), 725.
• 10. Fan G.H., Wang L.Z,. Qiu H.C. et al.: Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 1999,56(1), 39.
• 11. Koob G.F., Le Moal M.: Drug addiction, deregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24, 97.
• 12. Larson A.A., Kovacs K.J., Spartz A.K.: Intrathecal Zn2+ attenuates morphine antinociception and the development of acute tolerance. Eur. J. Pharmacol. 2000, 407(3), 267.
• 13. Maldonado R„ Saiardi A„ Valverde O. et al.: Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 1997, 388(6642), 586.
• 14. Margolin A., Kantak K., Copenhaver M. et al.: A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients. J. Addict, Dis. 2003, 22(2), 49.
• 15. Nechifor M., Chelarescu D., Miftode M.: Magnesium influence on morphine--induced pharmacodependence in rats. Magnes. Res. 2004, 17(1), 7.
• 16. Nechifor M., Chelarescu D, Palamaru I.: Research about manganese influence on morphine induced pharmacodependence in rat. Trace Elem. Electrol. 2003, 22. 11.
• 17. Stengaard-Pedersen K.: Inhibition of encephalin binding to opiate receptors by zinc ions: possible physiological importance in the brain. Acta Pharmacol. Toxicol. 1982, 50(3), 213.
• 18. Trulson M.E., Arasteh K.: Morphine increases the activity of midbrain dopamine neurons in vitro. Eur. J. Pharmacol. 1985, 114(1), 105.
• 19. West A.R., Galloway M.P.: Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms. Neurochem: Int. 1998: 33(6), 493.